Diabetologie und Stoffwechsel is a prominent academic journal specializing in the fields of endocrinology, diabetes, and metabolism, published by GEORG THIEME VERLAG KG. Since its inception in 2006, this German journal has strived to disseminate cutting-edge research and innovative findings that advance the understanding of metabolic disorders and the management of diabetes. With an ISSN of 1861-9002 and an E-ISSN of 1861-9010, it caters to a diverse audience ranging from researchers to healthcare professionals and students in the medical field. While it currently holds a Q4 ranking in the 2023 Scopus quartiles for its area, the journal serves as a critical platform for emerging insights and discussions impacting diabetes care and research, fostering collaboration and knowledge-sharing in a rapidly evolving landscape. The convergence of its coverage until 2024 signifies a commitment to ongoing exploration into the complexities of metabolic health, making it a valuable resource for anyone passionate about these vital areas of health.

Primary Care Diabetes is a leading journal published by ELSEVIER SCI LTD, focusing on the intersection of diabetes care, endocrinology, and family medicine. Since its inception in 2007, the journal has made significant contributions to the field, achieving notable rankings in various categories, such as Q2 in Endocrinology, Diabetes and Metabolism, Q1 in Family Practice, and Q2 in Internal Medicine, as well as Nutrition and Dietetics for 2023. With an ISSN of 1751-9918 and an E-ISSN of 1878-0210, it serves as an essential resource for researchers, healthcare professionals, and students dedicated to advancing knowledge and practice in primary diabetes care. The journal's strong Scopus rankings reflect its commitment to publish high-quality research, fostering clinical practice improvements and enhanced patient outcomes. Although not open access, its articles are pivotal for anyone looking to stay ahead in the dynamic and vital domain of diabetes management.

Practical Diabetes is an esteemed journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Published by John Wiley & Sons Ltd, this journal serves as a vital resource for healthcare professionals, researchers, and students seeking to explore the latest findings and practical applications in the field of endocrinology. With an ISSN of 2047-2897, it has established itself as a respected outlet for impactful research since its inception in 2011, with a convergence period extending until 2024. Although currently listed in Q4 for Endocrinology, Diabetes, and Metabolism and Q3 for Internal Medicine, the journal is committed to improving its rank and increasing its relevance in a competitive academic landscape. While not an open-access publication, Practical Diabetes provides valuable insights and evidence-based practices that are crucial for improving patient outcomes. Researchers and practitioners alike will find a wealth of knowledge to inform their work and enhance their understanding of diabetes management, making this journal an essential addition to any academic library collection.

Diabetes Mellitus, published by the Endocrinology Research Centre in the Russian Federation, is an esteemed open-access journal dedicated to the field of endocrinology, diabetes, and metabolism. Since its inception in 1998, this journal has been a pivotal platform for disseminating cutting-edge research and comprehensive reviews that address the multifaceted challenges posed by diabetes. With its current quartile ranking of Q4 in Endocrinology and the associated fields, as well as commendable involvement in the broader scope of Internal Medicine, Diabetes Mellitus plays a crucial role in enhancing clinical practices and informing innovative therapeutic strategies. The journal caters to a diverse audience of researchers, healthcare professionals, and students, particularly those seeking to expand their knowledge and improve patient outcomes in diabetes care. With a commitment to fostering scientific conversation and collaboration, Diabetes Mellitus is an invaluable resource for anyone engaged in the fight against diabetes and its complications.

Diabetes Therapy is a prominent open access journal published by SPRINGER HEIDELBERG, dedicated to advancing our understanding of diabetes management and therapeutic strategies. Since its inception in 2010, the journal has provided a platform for high-quality research, showcasing innovative studies and clinical advances aimed at improving care for individuals with diabetes. With an established impact factor and categorized within the Q2 quartile in both Endocrinology, Diabetes and Metabolism and Internal Medicine in 2023, it ranks among the top journals in its field, reflecting its significant contribution to medical knowledge. Researchers, healthcare professionals, and students benefit from its comprehensive coverage of critical topics, ranging from pharmacological advancements to lifestyle interventions and cutting-edge technologies in diabetes management. With a Scopus rank placing it 35th in Internal Medicine, and 68th in Endocrinology, Diabetes, and Metabolism, Diabetes Therapy is recognized for its robust peer-reviewed content, making it an essential resource for anyone engaged in diabetes research and care.

The International Journal of Diabetes in Developing Countries, published by SPRINGER INDIA, stands as a pivotal resource in the field of diabetes research, particularly focusing on the challenges and advancements in diabetes management within developing nations. With an ISSN of 0973-3930 and an E-ISSN of 1998-3832, this journal has been fostering knowledge exchange since its inception in 2001, converging its focus over multiple years to maintain relevance through 2024. As a peer-reviewed journal, it holds a significant position within the Q4 category of Endocrinology, Diabetes and Metabolism and Q3 in Internal Medicine, showcasing its commitment to addressing critical issues regarding diabetes care in diverse populations. The journal is crucial for researchers, healthcare professionals, and students seeking to further their understanding of diabetes in resource-limited settings. Although it operates without an open access model, the journal ensures rigorous peer review, maintaining high academic standards that benefit the growing field of diabetes research. With its address located in the heart of New Delhi, India, this publication serves as a vital repository for valuable insights and innovative strategies aimed at combating diabetes in developing countries.

The Journal of Diabetes, published by WILEY, is a premier Open Access platform since 2022, dedicated to advancing knowledge in the fields of endocrinology, diabetes, and metabolism. With an ISSN of 1753-0393 and an E-ISSN of 1753-0407, this journal provides a vital resource for researchers and practitioners looking to keep up with the latest findings and trends in diabetes management and treatment. As of 2023, it holds a commendable Q2 rating in its category and ranks #78 out of 244 in the Scopus classification, placing it in the 68th percentile, thus affirming its significance in the academic community. Covering a timeline from 2009 to 2024, the journal invites submissions that contribute to the understanding of diabetes pathophysiology, innovative therapies, and clinical practices, making it an essential read for anyone dedicated to improving patient outcomes in diabetes care.

The Journal of Diabetes Science and Technology, published by SAGE Publications Inc, is a premier academic journal that spans vital research and innovative advancements in the fields of diabetes management, bioengineering, and biomedical engineering. With an impressive impact factor reflected in its Q1 rankings across multiple categories such as Bioengineering and Internal Medicine as of 2023, this journal serves as an invaluable resource for researchers, healthcare professionals, and students dedicated to understanding and improving diabetes care and treatment. The journal invites contributions that encompass a wide range of scientific discoveries, methodologies, and technological innovations affecting diabetes and metabolism, ensuring a comprehensive platform for the dissemination of pivotal research findings. Although not an open-access journal, it provides highly curated content that reflects the cutting-edge advancements and emerging trends in diabetes science, making it an essential reference point for the scientific community.

Journal of Diabetes Investigation is a prestigious open-access journal published by WILEY, dedicated to advancing knowledge in the fields of Endocrinology, Diabetes, and Metabolism. With its ISSN 2040-1116 and E-ISSN 2040-1124, the journal provides a vital platform for researchers, healthcare professionals, and students to disseminate high-quality research, foster innovative ideas, and engage with cutting-edge developments in diabetes investigation. Since its inception in 2010, the journal has established a solid reputation, ranking in Q2 for Endocrinology and Diabetes and Metabolism, and Q1 for both Internal Medicine and Miscellaneous Medicine categories in 2023. Its Scopus rankings further underscore its impact, notably at the 76th percentile in Internal Medicine. The open access model, adopted in 2014, ensures that vital information is freely available, promoting global collaboration and knowledge sharing. The journal is not only a reflection of Australia's commitment to medical research but also a beacon for advancements that can ultimately enhance patient outcomes in diabetes care.

DIABETES CARE, published by the American Diabetes Association, is a premier journal dedicated to advancing the understanding and management of diabetes and related metabolic disorders. Since its inception in 1978, this journal has maintained a commitment to disseminating high-quality research, evidenced by its prestigious ranking in the Q1 category across multiple fields including Advanced and Specialized Nursing, Endocrinology, Diabetes and Metabolism, and Internal Medicine. With an impressive impact factor and distinguished Scopus rankings, DIABETES CARE serves as an essential resource for researchers, clinicians, and students alike, facilitating the exchange of knowledge and fostering innovation in diabetes care. Although not an open-access publication, the journal offers various ways to access groundbreaking studies and advancements in the field. This commitment to excellence reflects the journal's vital role in shaping diabetes research and clinical practices globally.